50 employees
NephroGenex is a drug-development company focusing on kidney disease and progression of diabetic kidney disease.
2004
$3.3M
from 1 investors over 1 rounds
NephroGenex raised $3.3M on July 6, 2007
Investors: BioStratum Incorporated